Company Xtant Medical Holdings Inc Nyse

Equities

US98420P1003

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Medical Devices & Implants

Inactive Instrument

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.

USD in Million	2022	Weight	2023	Weight	Delta
Orthobiologics 64.2 %	47	81.3 %	59	64.2 %	+24.31%
Spinal Implant 35.8 %	11	18.7 %	33	35.8 %	+202.34%

USD in Million	2022	Weight	2023	Weight	Delta
United States 94.0 %	57	98.6 %	86	94.0 %	+50.21%
Rest of World 6.0 %	1	1.4 %	5	6.0 %	+574.23%

Managers	Title	Age	Since
Sean Browne CEO	Chief Executive Officer	58	19-10-06
Scott Neils DFI	Director of Finance/CFO	40	19-07-31
Mark Schallenberger COO	Chief Operating Officer	-	23-01-15
Kevin Brandt PRN	Corporate Officer/Principal	59	18-07-08
Stephen C. Smith LAW	General Counsel	-	14-01-31

Members of the board	Title	Age	Since
Lori Mitchell-Keller BRD	Director/Board Member	58	23-05-15
John Bakewell BRD	Director/Board Member	62	18-01-31
Robert McNamara BRD	Director/Board Member	67	18-01-31
Sean Browne CEO	Chief Executive Officer	58	19-10-06
Jonn Beeson BRD	Director/Board Member	55	23-04-30
Stavros Vizirgianakis CHM	Chairman	53	22-08-22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	130,216,541	119,413,642 ( 91.70 %)	0	91.70 %

Name	Equities	%	Valuation
OrbiMed Advisors Private Equity 56.19 %	73,114,592	56.19 %	86 M $
Altium Capital Management LP 6.170 %	8,027,593	6.170 %	9 M $
Stavros Vizirgianakis 4.775 %	6,213,125	4.775 %	7 M $
Nantahala Capital Management LLC 3.074 %	4,000,000	3.074 %	5 M $
Sean Browne 1.773 %	2,306,990	1.773 %	3 M $
Vanguard Group, Inc. (Subfiler) 1.153 %	1,499,993	1.153 %	2 M $
Jonn Beeson 0.9319 %	1,212,501	0.9319 %	1 M $
Kevin Brandt 0.7686 %	1,000,069	0.7686 %	1 M $
Renaissance Technologies LLC 0.5694 %	740,910	0.5694 %	866 865 $
Scott Neils 0.5107 %	664,423	0.5107 %	777 375 $

Xtant Medical Holdings, Inc.

664 Cruiser Lane

59714, Belgrade

http://www.xtantmedical.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Medical Devices & Implants

	1st Jan change	Capi.
STRYKER CORPORATION	+13.16%	128B
SMITH & NEPHEW PLC	-8.76%	10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+3.60%	8.82B
INSPIRE MEDICAL SYSTEMS, INC.	+19.75%	7.19B
GLAUKOS CORPORATION	+22.28%	4.99B
AXONICS, INC.	+7.55%	3.4B
ENOVIS CORPORATION	-0.21%	3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-4.80%	2.14B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-4.72%	2B

Medical Devices & Implants